KK

Kuldip Kumar Bhasin

Active Director Director DIN 09250008
DIN 09250008 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Sep 2021
Shareholding value •••• Premium profile

About Kuldip Kumar Bhasin

Data last updated:

Kuldip Kumar Bhasin is a Director at Nectar Life Sciences Limited (since 2021), Director at Nectar Life Sciences Limited (since 2021) and Director at Nureca Limited (since 2025). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹3,472 Cr; the largest is Nectar Life Sciences Limited at ₹1,675 Cr (FY 2025).

DIN 09250008
Primary Designation Director
Industry Pharma
First Appointment 21 Sep 2021
Oldest Company Age 31 yrs
Largest company Nectar Life Sciences Limited · ₹1,675 Cr (FY 2025)
Combined revenue ₹3,472 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nectar Life Sciences Limited L24232PB1995PLC016664
Director21 Sep 20211995₹1,675 Cr (FY 2025)Active
Nectar Life Sciences Limited L21000PB1995PLC016664
Director21 Sep 20211995₹1,675 Cr (FY 2025)Active
Nureca Limited L24304MH2016PLC320868
Director01 Jan 20252016₹122 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Nureca Limited
Nectar Life Sciences Limited
Nectar Life Sciences Limited
Premium access

Shareholding and investment profile for Kuldip Kumar Bhasin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuldip Kumar Bhasin

Kuldip Kumar Bhasin currently holds 3 directorships: Nectar Life Sciences Limited (Director, since 21 Sep 2021, revenue ₹1,675 Cr (FY 2025)); Nectar Life Sciences Limited (Director, since 21 Sep 2021, revenue ₹1,675 Cr (FY 2025)); Nureca Limited (Director, since 01 Jan 2025, revenue ₹122 Cr (FY 2025)).

Kuldip Kumar Bhasin was first appointed on 21 Sep 2021 as Director at Nectar Life Sciences Limited. The most recent appointment on record is 01 Jan 2025 at Nureca Limited.

The 3 current companies of Kuldip Kumar Bhasin that report revenue have a combined latest revenue of ₹3,472 Cr: Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nectar Life Sciences Limited ₹1,675 Cr (FY 2025); Nureca Limited ₹122 Cr (FY 2025).

The current boards of Kuldip Kumar Bhasin's companies include Indu Pal Kaur (Nectar Life Sciences Limited), Rupinder Tewari (Nectar Life Sciences Limited), Sanjaymohan Singh Rawat (Nectar Life Sciences Limited), Sanjiv Goyal (Nectar Life Sciences Limited), Surulichamy Senthilkumar (Nectar Life Sciences Limited), Sushil Kapoor (Nectar Life Sciences Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available